In addition to developing the Rome Criteria for diagnosing Functional GI Disorders (FGIDs), the Rome Foundation appoints working teams that address other complex issues in the field. In choosing team members, the Board has selected senior-level members internationally who are directly involved in and who have published in the topic areas chosen by the Board. The purpose of these working team committees is to develop a summary of the research and literature to date and then offer guidelines or recommendations to help advance future research. The teams would then develop a manuscript to be published in a peer-reviewed journal.
Active Working Teams
Completed Working Teams
Food & Diet (2022)
William D. Chey, MD, Chair
Jan Tack, MD, PhD, Co-Chair
Communications Working Team
Douglas Drossman, MD, Chair
Post Infection IBS
Giovanni Barbara, MD, Chair
Madhusudan Grover, MD, Co-Chair
Brain Imaging in DGBI
Emeran A. Mayer, MD, Chair
Qasim Aziz PhD, Co-Chair
Neuromodulators for FGIDs
Douglas Drossman, MD, Chair
Jan Tack, MD, PhD, Co-Chair
Pharmacological Trials in Children with Constipation
Miguel Saps, MD, Chair
Multinational Cross-Cultural Research
Ami Sperber, MD, MSPH, Chair
Pharmacological Trials in Children with IBS
Miguel Saps, MD, Chair
Asian Working Teams for FGIDs
Kok Ann, Gwee MD, PhD, Chair
William E. Whitehead, PhD, Co-Chair
Brain-Gut Psychological Treatment Working Team
Laurie Keefer, PhD, Chair
Primary Care in FGIDs
A. P. Hungin, MD, Chair
Joel Heidelbaugh, MD, Co-Chair
Food and Diet (2013)
William D. Chey, MD, Chair
Jan Tack, MD, PhD, Co-Chair
Role of Intestinal Flora in FGIDs
Magnus Simrén, MD, PhD, Chair
Giovanni Barbara, MD, Co-Chair
Guidelines for Severity in IBS
Douglas Drossman, MD, Chair
Lin Chang, MD, Co-Chair
Guidelines for Brain Imaging in the FGIDs
Emeran A. Mayer, MD, Chair
Qasim Aziz, MD, PhD, Co-Chair
Outcomes/Endpoints in Pharmaceutical Clinical Trials
Michael Camilleri, MD, Chair